SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
+2.79%
1 Year Return
+26.83%
3 Year Return
+97.05%
5 Year Return
+189.63%
10 Year Return
–
AUM
$772M
AUM Growth
+$184M
(+31%)
Cap. Flow
+$179M
Cap. Flow
% of AUM
23.22%
Top 10 Holdings %
Top 10 Hldgs %
12.03%
Holding
719
New
321
Increased
119
Reduced
86
Closed
192
Top Buys
| 1 |
Amgen
AMGN
|
$11.2M |
| 2 |
Eli Lilly
LLY
|
$10.8M |
| 3 |
UnitedHealth
UNH
|
$10M |
| 4 |
Hologic
HOLX
|
$8.69M |
| 5 |
AbbVie
ABBV
|
$8.08M |
Top Sells
| 1 |
Amazon
AMZN
|
$13.5M |
| 2 |
Dell
DELL
|
$11.5M |
| 3 |
Molson Coors Class B
TAP
|
$9.36M |
| 4 |
Netflix
NFLX
|
$9.18M |
| 5 |
Bank of N.T. Butterfield & Son
NTB
|
$8.31M |
Sector Composition
| 1 | Healthcare | 21.43% |
| 2 | Consumer Discretionary | 15.02% |
| 3 | Technology | 12.58% |
| 4 | Communication Services | 9.39% |
| 5 | Financials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
Hasbro
HAS
$11.2B
| – | – |
-13,201
| Closed | -$1.05M |
|
652
Home BancShares
HOMB
$5.88B
| – | – |
-75,000
| Closed | -$1.56M |
|
653
Humana
HUM
$37B
| – | – |
-3,854
| Closed | -$682K |
|
654
iShares Biotechnology ETF
IBB
$5.8B
| – | – |
-14,400
| Closed | -$1.39M |
|
655
IMAX
IMAX
$1.6B
| – | – |
-6,893
| Closed | -$200K |
|
656
Intel
INTC
$107B
| – | – |
-46,587
| Closed | -$1.76M |
|
|
JWN
657
DELISTED
Nordstrom
JWN
| – | – |
-48,355
| Closed | -$2.51M |
|
658
Kellanova
K
$27.7B
| – | – |
-14,553
| Closed | -$1.06M |
|
659
Openlane
KAR
$3.09B
| – | – |
-349,545
| Closed | -$5.71M |
|
660
KeyCorp
KEY
$20.8B
| – | – |
-17,472
| Closed | -$213K |
|
661
CarMax
KMX
$9.11B
| – | – |
-37,516
| Closed | -$2M |
|
662
Lennar Class A
LEN
$36.7B
| – | – |
-25,174
| Closed | -$1.02M |
|
663
Liberty Latin America Class C
LILAK
$1.63B
| – | – |
-29,275
| Closed | -$773K |
|
664
LKQ Corp
LKQ
$8.32B
| – | – |
-52,101
| Closed | -$1.85M |
|
665
Cheniere Energy
LNG
$51.7B
| – | – |
-4,579
| Closed | -$200K |
|
666
Lam Research
LRCX
$130B
| – | – |
-58,400
| Closed | -$553K |
|
667
Matsons
MATX
$3.35B
| – | – |
-27,401
| Closed | -$1.09M |
|
668
McKesson
MCK
$85.3B
| – | – |
-5,329
| Closed | -$889K |
|
669
Mohawk Industries
MHK
$8.65B
| – | – |
-6,213
| Closed | -$1.25M |
|
670
Monster Beverage
MNST
$60.8B
| – | – |
-120,960
| Closed | -$2.96M |
|
671
Molina Healthcare
MOH
$9.44B
| – | – |
-11,457
| Closed | -$668K |
|
672
Medical Properties Trust
MPW
$2.77B
| – | – |
-50,000
| Closed | -$739K |
|
673
Neurocrine Biosciences
NBIX
$14.3B
| – | – |
-5,419
| Closed | -$274K |
|
674
Nabors Industries
NBR
$560M
| – | – |
-392
| Closed | -$238K |
|
675
Minerva Neurosciences
NERV
$16.6M
| – | – |
-2,560
| Closed | -$289K |
|